According to sources, so far only one traveller from Canada having symptoms of monkeypox infection had been isolated.
India logged 44,877 infections, while the death toll climbed to 5,08,665 with 684 fresh fatalities, the data updated at 8 am stated.
The active cases have further declined to 4,59,920 and comprise 1.50 per cent of the total infections, while the national COVID-19 recovery rate has improved to 97.18 per cent, the data updated at 8 am showed.
The interim findings of the trial in which the four drugs were tested in 405 hospitals across 30 countries, covering 11,266 adults, were released on 'medRxiv', a preprint server, on Thursday. The findings are under review for publication in a medical journal.
The active cases have further declined to 4,85,350 and comprise 1.59 per cent of the total infections, while the national COVID-19 recovery rate has improved to 97.09 per cent, the ministry said.
The active cases comprise 3.42 per cent of the total infections.
A single-day rise of 50,040 fresh COVID-19 infections took India's tally to 3,02,33,183, while the number of active cases dipped to 5,86,403, according to the Union health ministry data on Sunday.
Prime Minister Modi has said India's vaccine production and delivery capacity will be used for the benefit of all humanity to fight the COVID-19 pandemic. He said last week India was ready to do everything possible for a healthy planet.
A decrease of 3,856 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.
The death toll climbed to 4,46,918 with 260 daily fatalities, according to the data updated at 8 am.
The recoveries have crossed 1.02 crore.
With a record single-day rise of 3,49,691 new coronavirus infections, India's total tally of Covid-19 cases climbed to 1,69,60,172, while active cases crossed the 26-lakh mark, according to the Union health ministry data updated on Sunday.
Dr Arun Jamkar, former vice chancellor, Maharashtra University of Health Sciences, makes a strong case for reforming Indian medical education and believes that the National Medical Commission Bill is historic.
The total COVID-19 tally includes 9,287 cases of the Omicron variant.
India's coronavirus cases jumped from 10 lakh to 20 lakh in 21 days. Then it took 16 more days to race past 30 lakh, 13 days more to cross the 40-lakh mark and 11 days to go past 50 lakh. The cases rose from 50 lakh to 60 lakh in 12 days.
AI tech that study CT scans and X-Rays are being deployed as part of global efforts to tackle the coronavirus pandemic, according to LPU researchers. The system may enable doctors and medical staff even in remotest villages of the country to get quick results on the COVID-19 status of a patient.
An increase of 80,287 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.
India registered 2,68,833 new Covid infections in a day taking the tally to 3,68,50,962, which includes 6,041 Omicron variant cases, according to the Union health ministry data on Saturday.
The active cases increased to 9,55,319, the highest in 211 days, while the death toll climbed to 4,84,655 with 442 fresh fatalities, the data updated at 8 am stated.
A total of 5,15,385 COVID-19 patients have recovered so far with 19,870 patients having been cured and discharged in the last 24 hours till 8 am.
The active cases rose to 8,21,446, the highest in 208 days, while the death toll climbed to 4,84,213 with 277 fresh fatalities, the data updated at 8 am stated.
'This week will be crucial and we are prepared.'
The daily positivity rate was recorded at 2.50 per cent and the weekly positivity rate was 2.63 per cent. It has been below three per cent for the last 71 days.
Of the total cases, Maharashtra has the maximum at 797, followed by Delhi at 465, Rajasthan 236, Kerala 234, Karnataka 226, Gujarat 204 and Tamil Nadu 121.
Reacting to it, the vaccine maker said it is working towards resolving the issues cited during the inspection and the order of 20 million doses from the Brazilian government is still active.
Maharashtra has recorded the maximum number of 568 Omicron cases, followed by Delhi (382), Kerala (185), Rajasthan (174), Gujarat (152), and Tamil Nadu (121).
Maharashtra has recorded the maximum number of 510 cases, followed by Delhi (351), Kerala (156), Gujarat (136), Tamil Nadu (121) and Rajasthan (120).
It took 110 days for the COVID-19 cases in the country to reach one lakh while it had taken 59 days more to go past the 10-lakh post.
A total of 1,525 cases of Omicron variant of coronavirus have been detected across 23 states and Union Territories so far, out of which 560 have recovered or migrated, according to the Union health ministry's data updated on Sunday.
A total of 1,59,632 new coronavirus infections were reported in a day, the highest in 224 days.
The 3,81,947 active cases, down from 3,85,336 on Sunday, comprise 1.18 per cent of the total infections in the country, the lowest since March last year.
India's COVID-19 recoveries have reached closer to 2 million (19,19,842), while the actual caseload of the country stands at 6,76,900 on date and currently comprises only 25.57 per cent of the total positive cases.
The New York Times on Tuesday said Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.
The active cases in the country, however, have declined to 4,12,153 and comprises 1.29 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 97.37 per cent, the ministry data updated at 8 am showed.
Less than 50,000 daily new cases are being reported for 70 consecutive days.
The daily positivity rate was recorded at 2.58 per cent and the weekly positivity rate was recorded at 2.37 per cent, according to the ministry.
The minister said he was not supposed to say anything officially as he was still in touch with the union health ministry and the ICMR officials.
Results of an interim study recently published in The Lancet showed that two doses of Covaxin, also known as BBV152, had 77.8 per cent efficacy against symptomatic disease and present no serious safety concerns.
The US Food and Drug Administration had in February approved Johnson & Johnson's COVID-19 vaccine that works with just one dose for emergency use.
The active cases have declined to 4,08,212 and comprise 1.30 per cent of the total infections and the national COVID-19 recovery rate has been recorded at 97.36 per cent, the data updated at 8 am showed.
